Transfusion-Transmitted Hepatitis A Virus, France, 2018.
2018. Emerg Infect Dis. 2022 Jan [date cited]. https://doi.org/10.3201/eid2801.210403
Boyer F
France
Le Cam S
Lefort C
Mouna L
Roque-Afonso A-M
Suggested citation for this article: Lefeuvre C
blood donor
blood transfusion
et al. Transfusion-transmitted hepatitis A virus
hemovigilance
hepatitis A
hepatitis A virus
pathogen inactivation
screening
viruses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
entrez:
21
12
2021
pubmed:
22
12
2021
medline:
7
1
2022
Statut:
ppublish
Résumé
We report a transfusion-transmitted hepatitis A virus infection in an immunocompromised patient in France, detected shortly after a transfusion of pathogen-reduced pooled platelets. This case raises questions about the efficacy of donor screening methods. Additional safety measures, such as routine donation screening, should be considered.
Identifiants
pubmed: 34932935
doi: 10.3201/eid2801.210403
pmc: PMC8714218
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
219-223Références
Transfusion. 2009 Aug;49 Suppl 2:1S-29S
pubmed: 19686562
Transfusion. 2014 Sep;54(9):2202-6
pubmed: 24689888
Vox Sang. 2014 Oct;107(3):254-60
pubmed: 24806328
Euro Surveill. 2017 Apr 20;22(16):
pubmed: 28449730
J Hepatol. 2017 Sep 5;:
pubmed: 28887164
Euro Surveill. 2018 May;23(21):
pubmed: 29845926
Blood Transfus. 2019 Nov;17(6):433-448
pubmed: 31846608
Pharmeur Bio Sci Notes. 2017;2017:29-43
pubmed: 29017703
Transfusion. 2018 Nov;58(11):2669-2674
pubmed: 30267410
Transfus Med Rev. 2019 Jul;33(3):146-153
pubmed: 31327668
Emerg Infect Dis. 2017 Apr;23(4):590-596
pubmed: 28322704
J Med Virol. 1999 Feb;57(2):91-9
pubmed: 9892390
Transfus Med. 2020 Aug;30(4):243-244
pubmed: 32567077